These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19482007)

  • 1. CoA synthase is in complex with p85alphaPI3K and affects PI3K signaling pathway.
    Breus O; Panasyuk G; Gout IT; Filonenko V; Nemazanyy I
    Biochem Biophys Res Commun; 2009 Aug; 385(4):581-5. PubMed ID: 19482007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel CoA synthase isoform, which is primarily expressed in the brain.
    Nemazanyy I; Panasyuk G; Breus O; Zhyvoloup A; Filonenko V; Gout IT
    Biochem Biophys Res Commun; 2006 Mar; 341(4):995-1000. PubMed ID: 16460672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDC4 interacts with and regulates the dephospho-CoA kinase activity of CoA synthase.
    Gudkova D; Panasyuk G; Nemazanyy I; Zhyvoloup A; Monteil P; Filonenko V; Gout I
    FEBS Lett; 2012 Oct; 586(20):3590-5. PubMed ID: 22982864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoA Synthase (
    Ferrandon S; DeVecchio J; Duraes L; Chouhan H; Karagkounis G; Davenport J; Orloff M; Liska D; Kalady MF
    Cancer Res; 2020 Jan; 80(2):334-346. PubMed ID: 31704889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoA Synthase is phosphorylated on tyrosines in mammalian cells, interacts with and is dephosphorylated by Shp2PTP.
    Breus O; Panasyuk G; Gout IT; Filonenko V; Nemazanyy I
    Mol Cell Biochem; 2010 Feb; 335(1-2):195-202. PubMed ID: 19763791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling.
    Lee HJ; Kim YS; Sato Y; Cho YJ
    FEBS Lett; 2009 Aug; 583(15):2557-64. PubMed ID: 19619541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
    Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
    Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid-hormone-dependent activation of the phosphoinositide 3-kinase/Akt cascade requires Src and enhances neuronal survival.
    Cao X; Kambe F; Yamauchi M; Seo H
    Biochem J; 2009 Nov; 424(2):201-9. PubMed ID: 19747164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
    Schild C; Wirth M; Reichert M; Schmid RM; Saur D; Schneider G
    Mol Carcinog; 2009 Dec; 48(12):1149-58. PubMed ID: 19603422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of Ras-PI3K interaction in the endosome using BiFC.
    Tsutsumi K; Fujioka Y; Tsuda M; Kawaguchi H; Ohba Y
    Cell Signal; 2009 Nov; 21(11):1672-9. PubMed ID: 19616621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
    Porta C; Figlin RA
    J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes.
    Liu H; Li H; Guo L; Li M; Li C; Wang S; Jiang W; Liu X; McNutt MA; Li G
    Biochem Pharmacol; 2010 Feb; 79(3):516-23. PubMed ID: 19765550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
    Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
    Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells.
    Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A
    J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta.
    Fuhrman B; Gantman A; Khateeb J; Volkova N; Horke S; Kiyan J; Dumler I; Aviram M
    Cardiovasc Res; 2009 Oct; 84(1):145-54. PubMed ID: 19497963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation.
    Ng SK; Neo SY; Yap YW; Karuturi RK; Loh ES; Liau KH; Ren EC
    Biochem Biophys Res Commun; 2009 Sep; 387(2):310-5. PubMed ID: 19591801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
    Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
    Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.